Curis Inc (CRIS)

1.57
NASDAQ : Health Care
Prev Close 1.59
Day Low/High 1.56 / 1.63
52 Wk Low/High 1.47 / 3.72
Avg Volume 554.60K
Exchange NASDAQ
Shares Outstanding 143.88M
Market Cap 228.77M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr.

Curis Reports Second Quarter 2017 Financial Results

Curis Reports Second Quarter 2017 Financial Results

-- Management to host conference call today at 8:30 a.m. EDT --

Curis Reports First Quarter 2017 Financial Results

-- Management to host conference call today at 8:30 a.m. EDT --

Biotech Premarket Movers: Spectrum, BioCryst, Curis

Biotech Premarket Movers: Spectrum, BioCryst, Curis

Spectrum Pharmaceuticals, BioCryst Pharmaceuticals and Curis were among the biotech stock movers in premarket trading on Thursday.

Shark Bites: We Knew Today Would Be Slow, but Come On…

Shark Bites: We Knew Today Would Be Slow, but Come On…

Don't force it; there's no energy.

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a group of the top 30 companies developing cancer immunotherapy treatments and...

TheStreet Quant Rating: D (Sell)